90 related articles for article (PubMed ID: 18232056)
1. Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells.
Bian XW; Xu JP; Ping YF; Wang Y; Chen JH; Xu CP; Wu YZ; Wu J; Zhou XD; Chen YS; Shi JQ; Wang JM
Proteomics; 2008 Feb; 8(3):484-94. PubMed ID: 18232056
[TBL] [Abstract][Full Text] [Related]
2. Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
Chen JH; Bian XW; Yao XH; Gong W; Hu J; Chen K; Iribarren P; Zhao W; Zhou XD
Biochem Biophys Res Commun; 2006 Apr; 342(4):1368-74. PubMed ID: 16516855
[TBL] [Abstract][Full Text] [Related]
3. The differentiation-inducing effect of Nordy on HPV-16 subgenes-immortalized human endocervical cells H8.
Zhao J; Zhao Y; Chen W; Li YM; Bian XW
Anticancer Drugs; 2008 Aug; 19(7):713-9. PubMed ID: 18594213
[TBL] [Abstract][Full Text] [Related]
4. [Nordy inhibits cell proliferation and angiogenic factor production of malignant human glioma cells mediated by formylpeptide receptor].
Yao XH; Ping YF; Bian XW; Chen JH; Wang QL; Jiang XF
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):479-84. PubMed ID: 17459229
[TBL] [Abstract][Full Text] [Related]
5. [Effect of nordy on biological behaviors of malignant glioma cell line U87MG and the analysis of differential expression proteome].
Xu JP; Liu H; Bian XW; Chen JH; Zhou XD; Wu YZ
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):609-13. PubMed ID: 18070450
[TBL] [Abstract][Full Text] [Related]
6. [Effect of nordy on FPR function of malignant human glioma cell line U87].
Chen JH; Bian XW; Yao XH; Yang SX; Xu CR; Zhou XD; Ping YF
Yao Xue Xue Bao; 2007 Mar; 42(3):257-62. PubMed ID: 17520823
[TBL] [Abstract][Full Text] [Related]
7. A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
Chen JH; Yao XH; Gong W; Hu J; Zhou XD; Chen K; Liu H; Ping YF; Wang JM; Bian XW
J Neurooncol; 2007 Sep; 84(3):223-31. PubMed ID: 17377739
[TBL] [Abstract][Full Text] [Related]
8. [Effect of nordy on the function of endothelial progenitor cells from human umbilical cord blood induced by vascular endothelial growth factor].
Zhang HR; Xu CP; Chen FL; Bian XW
Yao Xue Xue Bao; 2008 Feb; 43(2):133-7. PubMed ID: 18507338
[TBL] [Abstract][Full Text] [Related]
9. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.
Wang B; Yu SC; Jiang JY; Porter GW; Zhao LT; Wang Z; Tan H; Cui YH; Qian C; Ping YF; Bian XW
Stem Cell Rev Rep; 2011 Jun; 7(2):458-70. PubMed ID: 20809257
[TBL] [Abstract][Full Text] [Related]
12. The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration.
Lopez RA; Goodman AB; Rhodes M; Blomberg JA; Heller J
Anticancer Drugs; 2007 Sep; 18(8):933-9. PubMed ID: 17667599
[TBL] [Abstract][Full Text] [Related]
13. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
14. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
Yang X; Cui W; Yu S; Xu C; Chen G; Gu A; Li T; Cui Y; Zhang X; Bian X
PLoS One; 2014; 9(1):e85759. PubMed ID: 24454929
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of high molecular weight FGF-2 forms inhibits glioma growth by acting on cell-cycle progression and protein translation.
Lemiere S; Azar R; Belloc F; Gürsel D; Pyronnet S; Bikfalvi A; Auguste P
Exp Cell Res; 2008 Dec; 314(20):3701-11. PubMed ID: 18930044
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of combination therapy against human glioma xenograft by differentiation-inducing agent and cytotoxic chemotherapeutic drug].
Shi MG; Huang Q; Dong J; Sun ZF; Lan Q
Ai Zheng; 2002 Oct; 21(10):1090-4. PubMed ID: 12508650
[TBL] [Abstract][Full Text] [Related]
19. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
